Use of an advanced form of the commonly used polymerase chain reaction (PCR) method to analyze circulating tumor cells (CTCs) may greatly increase the ability to diagnose early-stage cancer, ...

A new system for isolating rare circulating tumor cells (CTCs) – living solid tumor cells found at low levels in the bloodstream – shows significant improvement over previously developed devices and ...

We still mislabel cancer. Calling an illness "prostate cancer" or "breast cancer" doesn't get to the core of the problem. That classification system—using organs and parts of bodies—is far too broad.

Detecting circulating tumor cells (CTCs) in the blood can play an important role in early diagnosis, characterization of cancer subtypes, treatment monitoring and metastasis. Researchers have ...

Circulating tumor cells captured with a microchip-based device developed at the Massachusetts General Hospital (MGH) Center for Engineering in Medicine and the MGH Cancer Center can be cultured to ...

(Nanowerk News) The ability to detect circulating tumor cells (CTCs) as they travel through the blood can play an important role in early diagnosis, characterization of cancer subtypes, treatment ...

Identifying a single cancer cell in a sample of whole blood is akin to finding a needle in the proverbial haystack. However, a team from the Massachusetts General Hospital Cancer Center has developed ...

The genetic and functional characterization of circulating tumour cells (CTCs) isolated from the blood of patients with cancer over the course of therapy, might support the identification of ...

(Nanowerk News) A team of bioengineers, molecular biologists, and clinicians used a novel rare cell-sorter to isolate breast cancer cells from the blood of patients, with the aim of identifying the ...

Circulating tumor cells captured with a microchip-based device developed at the Massachusetts General Hospital (MGH) Center for Engineering in Medicine and the MGH Cancer Center can be cultured to ...